Barclays starts coverage of Baxter International stock at Underweight
Published on 10/08/2026 at 11:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Baxter International (ISIN US0718131099) was trading at EUR 21.27 at Lang & Schwarz on October 8, 2026 at 11:35 a.m. CEST, down 1.39 percent versus the EUR 21.57 prior close. On October 7, 2026, Barclays initiated coverage with an Underweight rating and a USD 20.00 price target, according to MarketBeat.
Barclays sets a USD 20 target
The target is below the euro reference price, but the currencies are different and therefore do not provide a valid upside or downside calculation against the Lang & Schwarz quote. Barclays's rating adds a fresh counterweight to the recent analyst picture rather than changing Baxter's reported operating figures.
Citigroup had already lowered its price target from USD 28.00 to USD 27.00 while keeping a Neutral rating on October 5, 2026, MarketBeat reported. The two calls show a divided analyst view, with one major house assigning a bearish rating and another maintaining a neutral stance.
Second-quarter revenue rose 5.30 percent
Baxter reported USD 2.96 billion in revenue for the second quarter of 2026, up 5.30 percent from USD 2.81 billion in the year-earlier quarter, according to MarketBeat. The quarter's revenue also exceeded the USD 2.80 billion consensus estimate by USD 0.16 billion, giving investors a concrete operating comparison alongside the cautious ratings.
Baxter's portfolio spans intravenous solutions, infusion pumps, injectable medicines, surgical products, nutrition therapies and connected-care technologies. The next scheduled reporting date is October 29, 2026, when Baxter will discuss its third-quarter 2026 results, according to Yahoo Finance.
Stock trades below its prior close
At Lang & Schwarz, Baxter International stock stood at EUR 21.27 on October 8, 2026 at 11:35 a.m. CEST, down 1.39 percent from the EUR 21.57 prior close. The stock's primary listing is on the NYSE in USD, while the German investor reference in this article remains the euro quote.
The further course of trading is shown by the continuously updated real-time quote of Baxter International stock.
Baxter International stock facts
- Company: Baxter International Inc.
- ISIN: US0718131099
- Ticker: BAX
- Primary exchange: NYSE
- Price Lang & Schwarz as of October 8, 2026, 11:35 a.m. CEST: EUR 21.27
- Change versus prior close: minus 1.39 percent
- Prior close Lang & Schwarz October 7, 2026: EUR 21.57
- Market capitalization: USD 12.4 billion as of October 7, 2026
- 52-week range: USD 15.73-30.00 as of October 7, 2026
- Sector / Industry: Healthcare / Medical Instruments and Supplies
